Nucleotide sequences and functions of the Epstein-Barr virus latent membrane protein 1 genes isolated from salivary gland lymphoepithelial carcinomas.
Epstein-Barr virus (EBV) infection is associated with salivary gland lymphoepithelial carcinoma (SLEC) and nasopharyngeal carcinoma (NPC). EBV is a ubiquitous herpes virus world wide, but EBV-associated SLEC and NPC are prevalent in restricted regions such as south areas of China, Southeastern Asia and Greenland (Eskimos). To examine whether particular EBV variants play roles in the development of SLEC and NPC, we isolated the complete EBV LMP1 genes from 12 paraffin-embedded biopsy samples of SLECs isolated from China, Taiwan and Russia, and compared these LMP1 genes with those of NPC (CAO) and the prototype B95-8 EBV. Nucleotide sequence analysis showed that SLECs LMP1 is more similar to that of CAO than that of prototype B95-8. The analysis also identified several conserved (67-100%) variations in SLEC-LMP1 and CAO-LMP1 distinct from B95-8-LMP1. These included 10-amino acid deletion, 5-amino acid deletion and 12-single amino acid variations. A SLEC-LMP1 gene with the aforementioned conserved variations inhibited the growth of an embryonic kidney cell line (293T), highly activated the NF-kappaB pathway, and these activities were equivalent to those of B95-8 and CAO. These findings suggest that the biological functions of SLEC-LMP 1 are similar to those of B95-8-LMP1 and CAO-LMP1, and that these amino acid variations including the well-known 10-aa deletion did not affect these two prominent activities. While the present results could not uncover functional differences between SLEC-LMP1 and B95-8-LMP1, the nucleotide sequences and the molecular clone of LMP1 directly isolated from SLEC patients will be a useful tool to identify the high-pathogenic EBV strain(s), associated with SLEC and NPC.
Jen
Kai Yu
KY
Division of Oral Pathology, Department of Tissue Regeneration and Reconstruction, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-Dori, Niigata, 951-8510, Japan.
Higuchi
Masaya
M
Cheng
Jun
J
Li
Jiang
J
Wu
Lan Yan
LY
Li
Ying Fang
YF
Lin
Han Liang
HL
Chen
Zhilong
Z
Gurtsevitch
Vladimir
V
Fujii
Masahiro
M
Saku
Takashi
T
D000595:Amino Acid Sequence; D001483:Base Sequence; D002294:Carcinoma, Squamous Cell / Q000821:virology*; D002453:Cell Cycle; D002455:Cell Division; D002460:Cell Line; D004279:DNA, Viral / Q000235:genetics; D020031:Epstein-Barr Virus Infections / Q000821:virology*; D005814:Genes, Viral; D014644:Genetic Variation; D004854:Herpesvirus 4, Human / Q000235:genetics* / Q000302:isolation & purification / Q000502:physiology; D006801:Humans; D008969:Molecular Sequence Data; D016328:NF-kappa B / Q000378:metabolism; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D012468:Salivary Gland Neoplasms / Q000821:virology*; D017386:Sequence Homology, Amino Acid; D014162:Transfection; D014763:Viral Matrix Proteins / Q000235:genetics* / Q000502:physiology
D004279:DNA, Viral; C037662:EBV-associated membrane antigen, Epstein-Barr virus; D016328:NF-kappa B; D011994:Recombinant Proteins; D014763:Viral Matrix Proteins
Virology. 2000 Jun 20;272(1):204-17
10873763
Arkh Patol. 2003 Mar-Apr;65(2):35-9
15357246
Oncogene. 2000 Mar 9;19(11):1400-10
10723131
Cancer Res. 2000 Oct 1;60(19):5589-93
11034108
J Biol Chem. 2003 Dec 5;278(49):48942-9
14523018
J Virol. 1993 Mar;67(3):1638-46
8382313
Int J Cancer. 1997 Jul 17;72(2):225-30
9219824
Virus Res. 1999 Mar;60(1):41-54
10225273
Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9150-4
8415670
J Virol. 1998 Oct;72(10):7900-8
9733827
J Virol. 1994 Jul;68(7):4369-76
8207810
Int J Cancer. 1992 Jul 30;51(6):949-55
1322379
J Virol. 1989 Jun;63(6):2469-75
2542565
Int J Cancer. 2003 Jul 10;105(5):654-60
12740914
Semin Cancer Biol. 2002 Dec;12(6):473-87
12450733
J Virol. 2004 Jul;78(13):7131-7
15194789
Blood. 1997 Jul 1;90(1):323-30
9207468
Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4675-80
11296297
Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1447-52
9037073
Oncogene. 1996 Nov 21;13(10):2243-54
8950992
Oncogene. 2001 Aug 30;20(38):5313-30
11536044
Cell Res. 2003 Jun;13(3):187-94
12862319
Proc Natl Acad Sci U S A. 1973 Sep;70(9):2487-91
4354852
Cancer Res. 2000 Apr 1;60(7):1845-8
10766170
Oncogene. 1993 Jun;8(6):1575-83
8389032
Hum Pathol. 1991 Aug;22(8):811-5
1651284
Oncogene. 1996 May 16;12(10):2129-35
8668338
Proc Natl Acad Sci U S A. 2000 May 23;97(11):6055-60
10811897
J Gen Virol. 1994 Oct;75 ( Pt 10):2729-40
7931159
Virology. 2001 Apr 10;282(2):278-87
11289810
Nature. 1984 Jul 19-25;310(5974):207-11
6087149
J Gen Virol. 1991 Oct;72 ( Pt 10):2399-409
1681026
Histopathology. 1997 Jul;31(1):75-82
9253628
Int J Cancer. 2001 Mar 15;91(6):815-21
11275985
Arctic Med Res. 1991 Apr;50(2):55-61
1646614
J Virol. 1995 May;69(5):2968-76
7707523
J Clin Pathol. 1995 Nov;48(11):1022-7
8543624
Am J Pathol. 1998 Jan;152(1):63-74
9422524
Cancer Lett. 2002 Feb 8;176(1):65-73
11790455